Business

TNI BioTech Names Terry Lierman of Summit Global Ventures as a Strategic Advisor

TNI BioTech Names Terry Lierman of Summit Global Ventures as a Strategic Advisor.

articleBiostax Corp.April 25, 20133/company/biostax-corp/news/tni-biotech-names-terry-lierman-of-summit-global-ventures-as-a-strategic-advisor
TNI BioTech Names Terry Lierman of Summit Global Ventures as a Strategic Advisor

About this update from Biostax Corp.

[{"type":"text","content":"\n\n\n\n\n\n\n\nTNI BioTech Names Terry Lierman of Summit Global Ventures as a Strategic Advisor\n\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:\"0in\";\n}\n\n\n\n\n\n\n\n\n\n\nTNI BioTech Names Terry Lierman of Summit Global Ventures as a Strategic Advisor\n\nPR Newswire\n\nBETHESDA Md., April 25, 2013\n\n\n\n\n\n\n\nBETHESDA Md., April 25, 2013 /PRNewswire/ -- TNI BioTech, Inc. (OTC PINK: TNIB) is pleased to announce that they have named Terry Lierman from the Summit Global Ventures as a strategic advisor to the company.  In this capacity, Mr. Lierman will provide strategic and tactical direction to improve operational productivity for the company's growth plans.\n\n\n\"Terry Lierman is renowned on capitol hill for both his political skills and his passionate support of improved healthcare and funding for medical research. He has proven over the last four decades that he has the ability to combine his entrepreneurial and political talents,\" said Noreen Griffin, chief executive officer and director of TNI BioTech, Inc.  \"His executive experience in the field of healthcare, especially as it applies to cancer and HIV/AIDS, will be invaluable over the coming year.\" Terry Lierman has served in leadership positions on the staff of the U.S. Senate, and is the founder of a number of companies and non-profit organizations that advance healthcare advocacy. \n\n\nCommenting on his appointment, Mr. Lierman said: \"TNI BioTech has the key ingredients of a successful company in the field of immunology: a highly motivated workforce and a passionate commitment to improving the lives of patients. I am looking forward to working with the TNI BioTech team.\"\n\n\n\nAbout Terry Lierman\n\n\n\n\nTerry Lierman began his career in the health field at the National Institutes of Health (NIH), where he assisted in budget and policy development, grants, and contracts. He then moved to the U.S. Senate Committee on Appropriations, where he was the staff director of both the labor Health and Human Services (HHS) appropriations committee and subcommittee. \n\n\nMr. Lierman founded several companies ...

More updates from Biostax Corp.